Completed PHASE4 INTERVENTIONAL NCT00221364

Trachoma Elimination Follow-up (TEF)

Trachoma Elimination With Repeated Mass Azithromycin Treatments

Sponsor: University of California, San Francisco

Interventions Mass treatment with oral azithromycin to an entire village

Updated 5 times since 2017 Last updated: Jul 13, 2015 Started: Mar 31, 2003 Primary completion: Apr 30, 2005 Completion: Apr 30, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Chlamydia and Trachoma and is currently completed. University of California, San Francisco leads this study, which shows 5 recorded versions since 2003 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Mar 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of California, San Francisco

Data source: University of California, San Francisco

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Addis Ababa, Ethiopia